Joshi Alumkal

Associate Professor

  • 2817 Citations
  • 25 h-Index
20022019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019

BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer

Coleman, D. J., Gao, L., King, C. J., Schwartzman, J., Urrutia, J., Sehrawat, A., Tayou, J., Balter, A., Burchard, J., Chiotti, K. E., Derrick, D. S., Sun, D., Xia, Z., Heiser, L. & Alumkal, J., Jan 1 2019, In : Oncogene.

Research output: Contribution to journalArticle

4 Scopus citations

Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Ferrari, A. C., Alumkal, J. J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. M., Apr 15 2019, In : Clinical Cancer Research. 25, 8, 1 p.

Research output: Contribution to journalComment/debate

Open Access

Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer

Ferrari, A. C., Alumkal, J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 52-63 12 p.

Research output: Contribution to journalArticle

6 Scopus citations

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

Chen, W. S., Aggarwal, R., Zhang, L., Zhao, S. G., Thomas, G., Beer, T. T., Quigley, D. A., Foye, A., Playdle, D., Huang, J., Lloyd, P., Lu, E., Sun, D., Guan, X., Rettig, M., Gleave, M., Evans, C. P., Youngren, J., True, L., Lara, P. & 8 others, Kothari, V., Xia, Z., Chi, K. N., Reiter, R. E., Maher, C. A., Feng, F. Y., Small, E. J. & Alumkal, J., Jan 1 2019, In : European Urology.

Research output: Contribution to journalArticle

11 Scopus citations

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer

Coleman, D. J., Gao, L., Schwartzman, J., Korkola, J., Sampson, D., Derrick, D. S., Urrutia, J., Balter, A., Burchard, J., King, C. J., Chiotti, K. E., Heiser, L. & Alumkal, J., Dec 1 2019, In : Scientific Reports. 9, 1, 3823.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

Nickols, N. G., Nazarian, R., Zhao, S. G., Tan, V., Uzunangelov, V., Xia, Z., Baertsch, R., Neeman, E., Gao, A. C., Thomas, G. V., Howard, L., De Hoedt, A. M., Stuart, J., Goldstein, T., Chi, K., Gleave, M. E., Graff, J. N., Beer, T. M., Drake, J. M., Evans, C. P. & 11 others, Aggarwal, R., Foye, A., Feng, F. Y., Small, E. J., Aronson, W. J., Freedland, S. J., Witte, O. N., Huang, J., Alumkal, J. J., Reiter, R. E. & Rettig, M. B., Dec 1 2019, In : Prostate Cancer and Prostatic Diseases. 22, 4, p. 531-538 8 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Multi-omics analyses detail metabolic reprogramming in lipids, carnitines, and use of glycolytic intermediates between prostate small cell neuroendocrine carcinoma and prostate adenocarcinoma

Gao, B., Lue, H. W., Podolak, J., Fan, S., Zhang, Y., Serawat, A., Alumkal, J., Fiehn, O. & Thomas, G., May 1 2019, In : Metabolites. 9, 5, 82.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Reply to a. Dalla volta et al

Aggarwal, R., Huang, J., Alumkal, J., Feng, F. Y., Zhang, L., Stuart, J. M. & Small, E. J., Feb 1 2019, In : Journal of Clinical Oncology. 37, 4, p. 351-352 2 p.

Research output: Contribution to journalLetter

Whole-genome and transcriptional analysis of treatment-emergent small-cell neuroendocrine prostate cancer demonstrates intraclass heterogeneity

Aggarwal, R. R., Quigley, D. A., Huang, J., Zhang, L., Beer, T. M., Rettig, M. B., Reiter, R. E., Gleave, M. E., Thomas, G. V., Foye, A., Playdle, D., Lloyd, P., Chi, K. N., Evans, C. P., Lara, P. N., Feng, F. Y., Alumkal, J. J. & Small, E. J., Jun 1 2019, In : Molecular Cancer Research. 17, 6, p. 1235-1240 6 p.

Research output: Contribution to journalArticle

4 Scopus citations
2018

Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: A multi-institutional prospective study

Aggarwal, R., Huang, J., Alumkal, J. J., Zhang, L., Feng, F. Y., Thomas, G. V., Weinstein, A. S., Friedl, V., Zhang, C., Witte, O. N., Lloyd, P., Gleave, M., Evans, C. P., Youngren, J., Beer, T. M., Rettig, M., Wong, C. K., True, L., Foye, A., Playdle, D. & 11 others, Ryan, C. J., Lara, P., Chi, K. N., Uzunangelov, V., Sokolov, A., Newton, Y., Beltran, H., Demichelis, F., Rubin, M. A., Stuart, J. M. & Small, E. J., Aug 20 2018, In : Journal of Clinical Oncology. 36, 24, p. 2492-2503 12 p.

Research output: Contribution to journalArticle

86 Scopus citations

DNA repair gene alterations and PARP inhibitor response in patients with metastatic castration-resistant prostate cancer

Lu, E., Thomas, G. V., Chen, Y., Wyatt, A. W., Lloyd, P., Youngren, J., Quigley, D., Bergan, R., Bailey, S., Beer, T. M., Feng, F. Y., Small, E. J. & Alumkal, J. J., Aug 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 8, p. 933-937 5 p.

Research output: Contribution to journalArticle

2 Scopus citations

Erratum: Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer (Cell (2018) 174(3) (758–769.e9), (S0092867418308420) (10.1016/j.cell.2018.06.039))

Quigley, D. A., Dang, H. X., Zhao, S. G., Lloyd, P., Aggarwal, R., Alumkal, J. J., Foye, A., Kothari, V., Perry, M. D., Bailey, A. M., Playdle, D., Barnard, T. J., Zhang, L., Zhang, J., Youngren, J. F., Cieslik, M. P., Parolia, A., Beer, T. M., Thomas, G., Chi, K. N. & 43 others, Gleave, M., Lack, N. A., Zoubeidi, A., Reiter, R. E., Rettig, M. B., Witte, O., Ryan, C. J., Fong, L., Kim, W., Friedlander, T., Chou, J., Li, H., Das, R., Li, H., Moussavi-Baygi, R., Goodarzi, H., Gilbert, L. A., Lara, P. N., Evans, C. P., Goldstein, T. C., Stuart, J. M., Tomlins, S. A., Spratt, D. E., Cheetham, R. K., Cheng, D. T., Farh, K., Gehring, J. S., Hakenberg, J., Liao, A., Febbo, P. G., Shon, J., Sickler, B., Batzoglou, S., Knudsen, K. E., He, H. H., Huang, J., Wyatt, A. W., Dehm, S. M., Ashworth, A., Chinnaiyan, A. M., Maher, C. A., Small, E. J. & Feng, F. Y., Oct 18 2018, In : Cell. 175, 3, 1 p.

Research output: Contribution to journalComment/debate

7 Scopus citations

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Quigley, D. A., Dang, H. X., Zhao, S. G., Lloyd, P., Aggarwal, R., Alumkal, J. J., Foye, A., Kothari, V., Perry, M. D., Bailey, A. M., Playdle, D., Barnard, T. J., Zhang, L., Zhang, J., Youngren, J. F., Cieslik, M. P., Parolia, A., Beer, T. M., Thomas, G., Chi, K. N. & 43 others, Gleave, M., Lack, N. A., Zoubeidi, A., Reiter, R. E., Rettig, M. B., Witte, O., Ryan, C. J., Fong, L., Kim, W., Friedlander, T., Chou, J., Li, H., Das, R., Li, H., Moussavi-Baygi, R., Goodarzi, H., Gilbert, L. A., Lara, P. N., Evans, C. P., Goldstein, T. C., Stuart, J. M., Tomlins, S. A., Spratt, D. E., Cheetham, R. K., Cheng, D. T., Farh, K., Gehring, J. S., Hakenberg, J., Liao, A., Febbo, P. G., Shon, J., Sickler, B., Batzoglou, S., Knudsen, K. E., He, H. H., Huang, J., Wyatt, A. W., Dehm, S. M., Ashworth, A., Chinnaiyan, A. M., Maher, C. A., Small, E. J. & Feng, F. Y., Jul 26 2018, In : Cell. 174, 3, p. 758-769.e9

Research output: Contribution to journalArticle

84 Scopus citations
6 Scopus citations

LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

Sehrawat, A., Gao, L., Wang, Y., Bankhead, A., McWeeney, S., King, C. J., Schwartzman, J., Urrutia, J., Bisson, W. H., Coleman, D. J., Joshi, S. K., Kim, D. H., Sampson, D. A., Weinmann, S., Kallakury, B. V. S., Berry, D. L., Haque, R., Van Den Eeden, S. K., Sharma, S., Bearss, J. & 4 others, Beer, T. T., Thomas, G., Heiser, L. & Alumkal, J., May 1 2018, In : Proceedings of the National Academy of Sciences of the United States of America. 115, 18, p. E4179-E4188

Research output: Contribution to journalArticle

34 Scopus citations

Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL

Chow, M., Gao, L., MacManiman, J. D., Bicocca, V. T., Chang, B., Alumkal, J. & Tyner, J., May 30 2018, (Accepted/In press) In : Oncogene. p. 1-12 12 p.

Research output: Contribution to journalArticle

Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer

Reichert, Z. R., Urrutia, J. & Alumkal, J., Jan 1 2018, (Accepted/In press) In : JAMA oncology.

Research output: Contribution to journalArticle

2017

Analysis of circulating cell-free DnA identifies multiclonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors

Quigley, D., Alumkal, J., Wyatt, A. W., Kothari, V., Foye, A., Lloyd, P., Aggarwal, R., Kim, W., Lu, E., Schwartzman, J., Beja, K., Annala, M., Das, R., Diolaiti, M., Pritchard, C., Thomas, G., Tomlins, S., Knudsen, K., Lord, C. J., Ryan, C. & 5 others, Youngren, J., Beer, T. T., Ashworth, A., Small, E. J. & Feng, F. Y., Sep 1 2017, In : Cancer Discovery. 7, 9, p. 999-1005 7 p.

Research output: Contribution to journalArticle

75 Scopus citations

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide

Rathkopf, D. E., Smith, M. R., Ryan, C. J., Berry, W. R., Shore, N. D., Liu, G., Higano, C. S., Alumkal, J. J., Hauke, R., Tutrone, R. F., Saleh, M., Maneval, E. C., Thomas, S., Ricci, D. S., Yu, M. K., de Boer, C. J., Trinh, A., Kheoh, T., Bandekar, R., Scher, H. I. & 1 others, Antonarakis, E. S., Jan 1 2017, In : Annals of Oncology. 28, 9, p. 2264-2271 8 p.

Research output: Contribution to journalArticle

27 Scopus citations

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

Wyatt, A. W., Annala, M., Aggarwal, R., Beja, K., Feng, F., Youngren, J., Foye, A., Lloyd, P., Nykter, M., Beer, T. M., Alumkal, J. J., Thomas, G. V., Reiter, R. E., Rettig, M. B., Evans, C. P., Gao, A. C., Chi, K. N., Small, E. J. & Gleave, M. E., Dec 1 2017, In : Journal of the National Cancer Institute. 109, 12

Research output: Contribution to journalArticle

72 Scopus citations

CT–Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield

Holmes, M. G., Foss, E., Joseph, G., Foye, A., Beckett, B., Motamedi, D., Youngren, J., Thomas, G. V., Huang, J., Aggarwal, R., Alumkal, J. J., Beer, T. M., Small, E. J. & Link, T. M., Aug 2017, In : Journal of Vascular and Interventional Radiology. 28, 8, p. 1073-1081.e1

Research output: Contribution to journalArticle

14 Scopus citations
12 Scopus citations

High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer

Friedlander, T. W., Graff, J., Zejnullahu, K., Anantharaman, A., Zhang, L., Paz, R., Premasekharan, G., Russell, C., Huang, Y., Kim, W., Aggarwal, R. R., Lin, A. M., Fong, L., Alumkal, J., Beer, T. T., Sharifi, N., Alyamani, M., Dittamore, R., Small, E. J., Paris, P. L. & 1 others, Ryan, C. J., 2017, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

8 Scopus citations

Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer

King, C. J., Woodward, J., Schwartzman, J., Coleman, D. J., Lisac, R., Wang, N. J., Hook, K. V., Gao, L., Urrutia, J., Dane, M. A., Heiser, L. M. & Alumkal, J. J., Jan 1 2017, In : Oncotarget. 8, 67, p. 111084-111095 12 p.

Research output: Contribution to journalArticle

2 Scopus citations

Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer

Armstrong, A. J., Halabi, S., Healy, P., Alumkal, J., Winters, C., Kephart, J., Bitting, R. L., Hobbs, C., Soleau, C. F., Beer, T. T., Slottke, R., Mundy, K., Yu, E. Y. & George, D. J., Aug 1 2017, In : European Journal of Cancer. 81, p. 228-236 9 p.

Research output: Contribution to journalArticle

28 Scopus citations

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: Post hoc analysis of PREVAIL

Bryce, A. H., Alumkal, J. J., Armstrong, A., Higano, C. S., Iversen, P., Sternberg, C. N., Rathkopf, D., Loriot, Y., De Bono, J., Tombal, B., Abhyankar, S., Lin, P., Krivoshik, A., Phung, D. & Beer, T. M., Jun 1 2017, In : Prostate Cancer and Prostatic Diseases. 20, 2, p. 221-227 7 p.

Research output: Contribution to journalArticle

17 Scopus citations

Safety and antitumor activity of apalutamide (ARN-509) in metastatic castration-resistant prostate cancer with and without prior abiraterone acetate and prednisone

Rathkopf, D. E., Antonarakis, E. S., Shore, N. D., Tutrone, R. F., Alumkal, J., Ryan, C. J., Saleh, M., Hauke, R. J., Bandekar, R., Maneval, E. C., De Boer, C. J., Yu, M. K. & Scher, H. I., Jul 15 2017, In : Clinical Cancer Research. 23, 14, p. 3544-3551 8 p.

Research output: Contribution to journalArticle

42 Scopus citations

Should Chemotherapy Be Used in Nonmetastatic Prostate Cancer?

Graff, J., Alumkal, J. & Beer, T. T., Jan 1 2017, In : JAMA oncology. 3, 1, p. 11-12 2 p.

Research output: Contribution to journalArticle

3 Scopus citations
2016

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

Coleman, D. J., Van Hook, K., King, C. J., Schwartzman, J., Lisac, R., Urrutia, J., Sehrawat, A., Woodward, J., Wang, N. J., Gulati, R., Thomas, G., Beer, T. T., Gleave, M., Korkola, J., Gao, L., Heiser, L. & Alumkal, J., 2016, In : Oncotarget. 7, 26, p. 40690 1 p.

Research output: Contribution to journalArticle

7 Scopus citations

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Graff, J., Alumkal, J., Drake, C. G., Thomas, G., Redmond, W. L., Farhad, M., Cetnar, J., Ey, F. F., Bergan, R., Slottke, R. & Beer, T. T., Aug 1 2016, In : Oncotarget. 7, 33, p. 52810-52817 8 p.

Research output: Contribution to journalArticle

169 Scopus citations

Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial

Alumkal, J., Chowdhury, S., Loriot, Y., Sternberg, C. N., de Bono, J. S., Tombal, B., Carles, J., Flaig, T. W., Dorff, T. B., Phung, D., Forer, D., Noonberg, S. B., Mansbach, H., Beer, T. T. & Higano, C. S., Dec 14 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

6 Scopus citations

Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort

Smith, M. R., Antonarakis, E. S., Ryan, C. J., Berry, W. R., Shore, N. D., Liu, G., Alumkal, J. J., Higano, C. S., Chow Maneval, E., Bandekar, R., de Boer, C. J., Yu, M. K. & Rathkopf, D. E., Dec 1 2016, In : European Urology. 70, 6, p. 963-970 8 p.

Research output: Contribution to journalArticle

60 Scopus citations

Raising the bar for therapeutic trials in advanced prostate cancer

Alumkal, J. & Beer, T. T., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 2958-2960 3 p.

Research output: Contribution to journalReview article

2 Scopus citations

Targeting Adaptive Pathways in Metastatic Treatment-Resistant Prostate Cancer: Update on the Stand Up 2 Cancer/Prostate Cancer Foundation–Supported West Coast Prostate Cancer Dream Team

Aggarwal, R., Beer, T. T., Gleave, M., Stuart, J. M., Rettig, M., Evans, C. P., Youngren, J., Alumkal, J., Huang, J., Thomas, G., Witte, O. & Small, E. J., Dec 1 2016, In : European Urology Focus. 2, 5, p. 469-471 3 p.

Research output: Contribution to journalArticle

5 Scopus citations
2015

A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

Alumkal, J. J., Slottke, R., Schwartzman, J., Cherala, G., Munar, M., Graff, J. N., Beer, T. M., Ryan, C. W., Koop, D. R., Gibbs, A., Gao, L., Flamiatos, J. F., Tucker, E., Kleinschmidt, R. & Mori, M., Apr 1 2015, In : Investigational New Drugs. 33, 2, p. 480-489 10 p.

Research output: Contribution to journalArticle

79 Scopus citations

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - Results of two parallel first-in-human phase I studies

Omlin, A., Jones, R. J., Van Der Noll, R., Satoh, T., Niwakawa, M., Smith, S. A., Graham, J., Ong, M., Finkelman, R. D., Schellens, J. H. M., Zivi, A., Crespo, M., Riisnaes, R., Nava-Rodrigues, D., Malone, M. D., Dive, C., Sloane, R., Moore, D., Alumkal, J. J., Dymond, A. & 5 others, Dickinson, P. A., Ranson, M., Clack, G., De Bono, J. & Elliott, T., Jun 22 2015, In : Investigational New Drugs. 33, 3, p. 679-690 12 p.

Research output: Contribution to journalArticle

28 Scopus citations

Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: Results from American College of Radiology Imaging Network 6687

Yu, E. Y., Duan, F., Muzi, M., Deng, X., Chin, B. B., Alumkal, J. J., Taplin, M. E., Taub, J. M., Herman, B., Higano, C. S., Doot, R. K., Hartfeil, D., Febbo, P. G. & Mankoff, D. A., Mar 1 2015, In : Journal of Nuclear Medicine. 56, 3, p. 354-360 7 p.

Research output: Contribution to journalArticle

36 Scopus citations

CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer

Guo, M., Alumkal, J., Drachova, T., Gao, D., Marina, S. S., Jen, J. & Herman, J. G., Jan 1 2015, In : Discovery Medicine. 19, 104, p. 151-158 8 p.

Research output: Contribution to journalArticle

11 Scopus citations

Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors

Geybels, M. S., Alumkal, J. J., Luedeke, M., Rinckleb, A., Zhao, S., Shui, I. M., Bibikova, M., Klotzle, B., van den Brandt, P. A., Ostrander, E. A., Fan, J. B., Feng, Z., Maier, C. & Stanford, J. L., Dec 12 2015, In : Clinical epigenetics. 7, 1, 128.

Research output: Contribution to journalArticle

15 Scopus citations
5 Scopus citations
2014

Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer

Goh, L. K., Liem, N., Vijayaraghavan, A., Chen, G., Lim, P. L., Tay, K. J., Chang, M., Low, J. S. W., Joshi, A., Huang, H. H., Kalaw, E., Tan, P. H., Hsieh, W. S., Yong, W. P., Alumkal, J. & Sim, H. G., Mar 13 2014, In : PloS one. 9, 3, e91666.

Research output: Contribution to journalArticle

7 Scopus citations

Orteronel for the treatment of prostate cancer

Van Hook, K., Huang, T. & Alumkal, J. J., Apr 2014, In : Future Oncology. 10, 5, p. 803-811 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen

Hussain, M., Corn, P. G., Michaelson, M. D., Hammers, H. J., Alumkal, J. J., Ryan, C. J., Bruce, J. Y., Moran, S., Lee, S. Y., Lin, H. M. & George, D. J., Aug 15 2014, In : Clinical Cancer Research. 20, 16, p. 4218-4227 10 p.

Research output: Contribution to journalArticle

25 Scopus citations

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer

Hussain, M., Carducci, M. A., Slovin, S., Cetnar, J., Qian, J., McKeegan, E. M., Refici-Buhr, M., Chyla, B., Shepherd, S. P., Giranda, V. L. & Alumkal, J. J., Apr 26 2014, In : Investigational New Drugs. 32, 5, p. 904-912 9 p.

Research output: Contribution to journalArticle

44 Scopus citations
2013

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation

Gao, L., Schwartzman, J., Gibbs, A., Lisac, R., Kleinschmidt, R., Wilmot, B., Bottomly, D., Coleman, I., Nelson, P., McWeeney, S. & Alumkal, J., May 21 2013, In : PloS one. 8, 5, e63563.

Research output: Contribution to journalArticle

69 Scopus citations

Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study

Weinmann, S., Van Den Eeden, S. K., Haque, R., Chen, C., Richert-Boe, K., Schwartzman, J., Gao, L., Berry, D. L., Kallakury, B. V. S. & Alumkal, J. J., Sep 1 2013, In : Prostate. 73, 13, p. 1371-1377 7 p.

Research output: Contribution to journalArticle

6 Scopus citations

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: Results from an open-label, multicenter phase i/ii study

Slovin, S. F., Higano, C. S., Hamid, O., Tejwani, S., Harzstark, A., Alumkal, J. J., Scher, H. I., Chin, K., Gagnier, P., McHenry, M. B. & Beer, T. M., Jul 1 2013, In : Annals of Oncology. 24, 7, p. 1813-1821 9 p., mdt107.

Research output: Contribution to journalArticle

332 Scopus citations

Targeted MET inhibition in castration-resistant prostate cancer: A randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisone

Ryan, C. J., Rosenthal, M., Ng, S., Alumkal, J., Picus, J., Gravis, G., Fizazi, K., Forget, F., Machiels, J. P., Srinivas, S., Zhu, M., Tang, R., Oliner, K. S., Jiang, Y., Loh, E., Dubey, S. & Gerritsen, W. R., Jan 1 2013, In : Clinical Cancer Research. 19, 1, p. 215-224 10 p.

Research output: Contribution to journalArticle

54 Scopus citations
1 Scopus citations
2012

C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results

Prins, R. C., Rademacher, B. L., Mongoue-Tchokote, S., Alumkal, J. J., Graff, J. N., Eilers, K. M. & Beer, T. M., Jan 1 2012, In : Urologic Oncology: Seminars and Original Investigations. 30, 1, p. 33-37 5 p.

Research output: Contribution to journalArticle

46 Scopus citations